Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Stanley Frankel
28 Sep 2026
Director
Buy
1,000
$6.00
$6.00K
Geno J Germano
25 Sep 2026
Director
Buy
2,609
$6.28
$16.38K
Melinda Brown
25 Sep 2026
Director
Buy
1,135
$6.27
$7.12K
Stanley Frankel
16 Dec 2025
Director
Buy
2,700
$4.70
$12.69K
Geno J Germano
16 Dec 2025
Director
Buy
3,000
$4.72
$14.16K
Melinda Brown
15 Dec 2025
Director
Buy
1,381
$4.97
$6.86K
Stanley Frankel
26 Sep 2025
Director
Buy
2,700
$4.97
$13.42K
Melinda Brown
22 Sep 2025
Director
Buy
1,400
$4.89
$6.85K
Kevin Buehler
25 Jun 2025
Director
Buy
5,076
$4.16
$21.12K
Melinda Brown
25 Jun 2025
Director
Buy
1,682
$4.14
$6.96K
Melinda Brown
26 Mar 2025
Director
Buy
1,839
$4.75
$8.74K
Kevin Buehler
26 Mar 2025
Director
Buy
4,523
$4.67
$21.12K
Geno J Germano
25 Mar 2025
Director
Buy
3,250
$5.30
$17.23K
Geno J Germano
30 Dec 2024
Director
Buy
3,605
$4.49
$16.19K
John Alexander Kelly
27 Dec 2024
Chief Financial Officer
Buy
2,113
$4.75
$10.04K
Kevin Buehler
27 Dec 2024
Director
Buy
4,320
$4.88
$21.08K
Melinda Brown
26 Dec 2024
Director
Buy
3,016
$4.55
$13.72K
John Alexander Kelly
21 Nov 2024
Chief Financial Officer
Buy
3,000
$6.76
$20.28K
John Alexander Kelly
17 Mar 2023
Chief Financial Officer
Buy
20,000
$0.86
$17.20K
John Alexander Kelly
23 Sep 2022
Chief Financial Officer
Buy
8,200
$1.23
$10.09K
John Alexander Kelly
22 Sep 2022
Chief Financial Officer
Buy
37,037
$1.34
$49.63K
John Alexander Kelly
22 Jun 2022
Chief Financial Officer
Buy
33,784
$1.50
$50.68K
John Alexander Kelly
17 Mar 2022
Chief Financial Officer
Buy
16,677
$3.08
$51.37K
Christopher Heery
19 Dec 2019
Chief Medical Officer
Buy
2,235
$12.08
$27.00K
Christopher Heery
19 Dec 2019
Chief Medical Officer
Buy
250
$12.09
$3.02K
Tony Dung Ling Yao
3 Apr 2019
Director
Buy indirect
6,487
$15.42
$100.03K
venBio Global Strategic Fund, L.P.
1 Apr 2019
Director
Buy indirect
50,000
$16.00
$800.00K
Fmr LLC
1 Apr 2019
See Remark 1
Buy indirect
50,000
$16.00
$800.00K

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019